This page lists references for further reading about dermatitis, including medications used in the treatment of dermatitis and other skin conditions that co-exist with dermatitis, such as rosacea, acne, eczema, and psoriasis.

  1. Camisa, Charles, M.D. Psoriasis, 1994, pp.7-75.

  2. Hall, John C., M.D.  Sauer's Manual of Skin Diseases, 8th Edition, 2000, pp.79-134.

  3. Hunter, J.A.A., M.D., J.A. Savin, M.D., and M.V. Dahl, M.D. Clinical Dermatology, 1989, pp.76-77.

  4. Mackie, Rona M.  Clinical Dermatology:  An Illustrated Textbook, 2nd Edition, 1987, pp.36-37,77,88.

  5. Pillsbury, Donald M., M.D., Walter B. Shelley, M.D., and Albert M. Kligman, M.D. Dermatology, 1956, p.729

  6. Rietschel, Robert L., M.D., Luis Conde-Salazar, M.D., An Goosens, M.D., and Niels K. Veien, M.D. Atlas of Contact Dermatitis, 1999, p.215.

  7. Dermatology Times, Vol.19 Issue 10.  October:  p.12, 1998.

  8. Whitman, L.R. and McGibbon, D.H. The Management of Psoriasis. International Journal of Clinical Practice. October: pp.487-491, 1998.

  9. Nicksin, Carole. "The heartbreak of ... psoriasis is a traumatic disease, but now there's hope for sufferers". Vegetarian Times, Issue 272. April: pp.24-27, 2000.

  10. Psoriasis Q & A. National Psoriasis Foundation, Inc., Portland, Oregon, 1998.

  11. Clear Up Psoriasis. ICN Pharmaceuticals, Inc, 1998.

  12. Rosacea-like dermatitis. Br Med J. 1969;3:545-546.

  13. Barankin B, Guenther L. Rosacea and atopic dermatitis. Two common oculocutaneous disorders. Can Fam Physician. 2002;48:721-724.

  14. Bardazzi F, Manuzzi P, Riguzzi G, Veronesi S. Contact dermatitis with rosacea. Contact Dermatitis. 1987;16:298.

  15. Boni R. [Rosacea, acne and other diseases of the seborrheic spectrum]. Schweiz Rundsch Med Prax. 2000;89:566-570.

  16. Corazza M, la Malfa W, Lombardi A, Maranini C, Virgili A. Role of allergic contact dermatitis in rosacea. Contact Dermatitis. 1997;37:40-41.

  17. Ellis, C.N., M.D., and M.A. Strawiski, M.D. Symposium on the Treatment of Skin: The Treatment of Perioral Dermatitis, Acne Rosacea, and Seborrheic Dermatitis. Medical Clinics of North America. 66:4, pages 819-830, 1982.

  18. Kanerva L, Alanko K, Jolanki R, Estlander T. Laboratory assistant's occupational allergic airborne contact dermatitis from nickel presenting as rosacea. Eur J Dermatol. 1999;9:397-398.

  19. Ljubojeviae S, Basta-Juzbasiae A, Lipozeneiae J. Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment. J Eur Acad Dermatol Venereol. 2002;16:121-126.

  20. Richardson DP. Seborrheic dermatitis and rosacea. Compr Ther. 1981;7:57-60.

  21. Sneddon IB. The treatment of steroid-induced rosacea and perioral dermatitis. Dermatologica. 1976;152 Suppl 1:231-237.

  22. Steigleder GK, Strempel A. [Rosacea-like dermatitis of the face. "Perioral dermatitis"]. Hautarzt. 1969;20:288.

  23. Tomita Y, Tagami H. Steroid-withdrawal rosacea-like dermatitis. J Dermatol. 1989;16:335-337.

  24. Urabe H, Koda H. Perioral dermatitis and rosacea-like dermatitis: clinical features and treatment. Dermatologica. 1976;152 Suppl 1:155-160.

  25. Urabe H. [Perioral dermatitis (rosacea-like dermatitis)--adverse effects of externally applied steroid preparations]. Nippon Rinsho. 1978;Suppl:2400-2401.

  26. Weber G. Rosacea-like dermatitis: contraindication or intolerance reaction to strong steroids. Br J Dermatol. 1972;86:253-259.

  27. Clark RAF, Nicol N, Adinoff AD: Atopic dermatitis. In: Sams WM, ed. Principles and Practice of Dermatology. New York: Churchill Livingstone; 1990: 365-380.

  28. Landow K: Atopic dermatitis. Current concepts support old therapies and spur new ones. Postgrad Med 1997 Mar; 101(3): 101-4, 107-8, 111-2 passim.

  29. Rudikoff D, Lebwohl M: Atopic dermatitis. Lancet 1998 Jun 6; 351(9117): 1715-21.

  30. Schultz Larsen F: Atopic dermatitis: an increasing problem. Pediatr Allergy Immunol 1996; 7(9 Suppl): 51-3.

  31. Leung DYM, Rhodes AR, Geha RS, et al. Atopic dermatitis. In: Fitzpatrick TR, et al, eds. Dermatology in general medicine. Fourth Edition. New York: McGraw-Hill, 1993:1543.

  32. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302.

  33. Leiferman KM, Ackerman SJ, Sampson HA, et al. Dermal deposition of eosinophil granule major basic protein in atopic dermatitis. N Engl J Med 1985;313:282.

  34. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128.

  35. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44.

  36. Hanifin JM, Cooper KD. Atopy and atopic dermatitis. J Am Acad Dermatol 1986;15:703.

  37. Rystedt I. Work-related hand eczema in atopics. Contact Dermatitis 1985;12:164.

  38. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994;94:870.

  39. Leung DYM. Role of IgE in atopic dermatitis. Curr Opinion Immunol 1993;5:956.

  40. Mudde GC, Van Reijsen FC, Boland GJ, et al. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990;69:335.

  41. Chan SC, Kim JW, Henderson WR, et al. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 1993;151:3345.

  42. Boguniewicz M, Leung DYM. Management of atopic dermatitis. In: Leung DYM, ed. Atopic dermatitis: from pathogenesis to treatment. Austin: R/tG Landes Co 1996:185.

  43. Sampson HA, Albergo R. Comparison of results of prick skin tests, RAST, and double-blind placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984;74:26.

  44. Jones SM, Sampson HA. The role of allergens in atopic dermatitis. In: Leung DYM, ed. atopic dermatitis: from pathogenesis to treatment. Austin: R/tG Landes Co, 1996:41.

  45. Sampson HA, McCaskill CC. Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients. J Pediatr 1985;107:669.

  46. Adinoff AD, Tellez P, Clark RAF. Atopic dermatitis and aeroallergen contact sensitivity. J Allergy Clin Immunol. 1988;81:736.

  47. Norris P, Schofield O, Camp R. A study of the role of house dust mite in atopic dermatitis. Br J Dermatol 1988;118:435.

  48. Hanifin JM. Atopic dermatitis: new therapeutic considerations. J Am Acad Dermatol 1991;24:1097.

  49. Nassif A, Chan SC, Storrs FJ, et al. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol 1994;130:1402.

  50. Sampson HA. The role of food allergy and mediator release in atopic dermatitis. J Allergy Clin Immunol 1988;81:635.

  51. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. 'Spontaneous' basophil histamine release and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989;321:228.

  52. Platts-Mills TAE, Mitchell EB, Rowntree S, et al. The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol 1983;8:233.

  53. Sanda T, Yasue T, Oohashi M, et al. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89:653.

  54. White A, Horne DJ, Varigos GA. Psychological profile of the atopic eczema patient. Australas J Dermatol 1990;31:13.

  55. Scheich G, Florin I, Rudolph R, et al. Personality characteristics and serum IgE level in patients with atopic dermatitis. J Psychosom Res 1993;37:637.

  56. Noren P, Melin L. The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis. Br J Dermatol 1989;121:359.

  57. Melin L, Frederiksen T, Noren P, et al. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol 1986;115:467.

  58. Horne DJ, White AE, Varigos GA. A preliminary study of psychological therapy in the management of atopic eczema. Br J Med Psychol 1989;62:241.

  59. Haynes SN, Wilson CC, Jaffe PG, et al. Biofeedback treatment of atopic dermatitis: controlled case studies of eight cases. Biofeedback Self Regul 1979;4:195.

  60. Hauser C, Prins C, Lacour M. The role of infectious agents. In: Leung DYM, ed. Atopic dermatitis: from pathogenesis to treatment. Austin: R/tG Landes Co, 1996:67.

  61. Lever R, Hadley K, Downey D, et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189.

  62. Novelli VM, Atherton DJ, Marshall WC. Eczema herpeticum. Clinical and laboratory features. Clin Pediatr 1988;27:231.

  63. Bork K, Brauninger W. Increasing incidence of eczema herpeticum: analysis of seventy-five cases. J Am Acad Dermatol 1988;19:1024.

  64. Kieffer M, Bergbrant IM, Faergemann J, et al. Immune reactions to Pityro-sporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 1990;22:739.

  65. Broberg A, Faergemann J, Johansson S, et al. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol 1992;72:187.

  66. Wilson BB, Deuell B, Mills TA. Atopic dermatitis associated with dermatophyte infection and Trichophyton hypersensitivity. Cutis 1993;51:191.

  67. Clemmensen OJ, Hjorth N. Treatment of dermatitis of the head and neck with ketoconazole in patients with type I hypersensitivity for Pityrosporum orbiculare. Semin Dermatol 1983;2:26.

  68. Doherty V, Sylvester DGH, Kennedy CTC, et al. Treatment of itching in atopic eczema with antihistamines with a low sedative profile. Br Med J 1989;298:96.

  69. Berth-Jones J, Graham-Brown RAC. Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 1989;121:635.

  70. Langeland T, Fagertun HE, Larsen S. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study. Allergy 1994;49:22.

  71. Hannuksela M, Kalimo K, Lammintausta K, et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis. Ann Allergy 1993;70:127.

  72. Drake LA, Fallon JD, Sober A, et al. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 1994;31:613.

  73. Shelley WB, Shelley ED, Talanin NY. Self-potentiating allergic contact dermatitis caused by doxepin hydrochloride cream. J Am Acad Dermatol 1996;34:143.

  74. Nicol NH. Atopic dermatitis: the (wet) wrap-up. Am J Nurs 1987;87:1560.

  75. George SA, Bilsland DJ, Johnson BE, et al. Narrow band (TL-01) UVB air conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993;128:49.

  76. Midelfart K, Stenvold SE. Voloden G. Combined UVB and UVA phototherapy of atopic eczema. Dermatologica 1985;171:95.

  77. Krutmann J, Czech W, Giepgen T, et al. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992;26:225.

  78. Krutmann J, Schopf E. High-dose UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:120.

  79. Morison WL, Parrish JA, Fitzpatrick TB. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol 1978;98:25.

  80. Honig B, Morison WL, Karp D. Photochemotherapy beyond psoriasis. J Am Acad Dermatol 1994;31:775.

  81. Fuenmayer M, DiPrisco MC, Champion RH. Specific hyposensitization in atopic dermatitis. Br J Dermatol 1979;101:697.

  82. Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992;22:440.

  83. Kaufman HS, Roth HL. Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo-controlled study. Ann Allergy 1974;32:321.

  84. Zachariae H, Cramers M, Herlin T, et al. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1985;114:48.

  85. Jacquemin MG, Machiels JJ, Lebrun PM, et al. Successful treatment of atopic dermatitis with complexes of allergen and specific antibodies. Lancet 1990;335:1468.

  86. Leroy BP, Boden G, Lachapelle JM, et al. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 1993;28:232.

  87. Leroy BP, Jacquemin MG, Lachapelle JM, et al. Allergen-sensitive atopic dermatitis is improved by injections of allergen combined with F(ab`)2 fragments of specific antibodies. Br J Dermatol 1995;132:599.

  88. Boguniewicz M, Jaffe HS, Izu A, et al. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 1990;88:365.

  89. Hanifin JM, Schneider LC, Leung DYM, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189.

  90. Reinhold U, Kukel S, Brzoska J, et al. Systemic interferon gamma treatment in severe atopic dermatitis. J Am Acad Dermatol 1993;29:58.

  91. Torrelo A, Harto A, Sendagorta E, et al. Interferon-alpha therapy in atopic dermatitis. Acta Derm Venereol 1992;72:370.

  92. Michils A, Farber CM, Van Vooren JP, et al. Sustained benefit of interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis. Br J Dermatol 1994;130:134.

  93. Jullien D, Nicolas JF, Frappaz A, et al. Alpha interferon treatment in atopic dermatitis. Acta Derm Venereol 1993;73:130.

  94. Paukkonen K, Fraki J, Horsmanheimo M. Interferon-alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis. Acta Derm Venereol 1993;73:141.

  95. Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe atopic dermatitis. Lancet 1991;338:137.

  96. Van Joost Th, Kozel MMA, Tank B, et al. Cyclosporine in atopic dermatitis: modulation in the expression of immunologic markers in lesional skin. J Am Acad Dermatol 1992;27:922.

  97. Wahlgren CF, Scheynius A, Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol 1990;70:323.

  98. van Joost T, Heule F, Korstanje M, et al. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994;130:634.

  99. de Prost Y, Bodemer C, Teillac D. Randomised double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:136.

  100. De Rie MA, Meinardi MHM, Bos JD. Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis. Acta Derm Venereol 1991;71:452.

  101. Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994;344:24.

  102. Sawai T, Ikai K, Uehara M. Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leukocytes from children with atopic dermatitis. Br J Dermatol 1995;132:22.

  103. Lester MR, Gately M, Trumble A, Leung DYM. Effects of IL-12 and staphylococcal toxic shock syndrome toxin-1 on the interferon-gamma response in atopic dermatitis. J Immunol 1995;154:6174.

  104. Hanifin JM, Chan SC, Cheng JB, et al. Type 4 phosphodieserase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 1996;107:51.

  105. Melnik B, Plewig G. Are disturbances of |gq-6-fatty acid metabolism involved in the pathogenesis of atopic dermatitis? Acta Derm Venereol (Stockh) 1992;176:77.

  106. Bjorneboe A, Soyland E, Bjorneboe GE, et al. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol 1987;117:463.

  107. Soyland E, Funk J, Rajka G, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol 1994;130:757.

  108. Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557.

  109. Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992;126:179.

  110. Sheehan MP, Rustin MH, Atherton DJ, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992;340:13.

  111. Harper J. Traditional Chinese medicine for eczema. Br Med J 1994;308:489.

  112. Davis EG, Pollock I, Steel HM. Chinese herbs for eczema. Lancet 1990;336:177

  113. Camp RD. Psoriasis. In: Rook A, Wilkinson DS, Ebling FJ, eds. Textbook of dermatology. 5th ed. Oxford: Blackwell Scientific, 1992:1391-458.

  114. Weinstein GD, Van Scott EJ. Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J Invest Dermatol 1965;45:257-62.

  115. Katz HI, Hien NT, Prawer SE, Mastbaum LI, Mooney JJ, Samson CR. Superpotent topical steroid treatment of psoriasis vulgaris.clinical efficacy and adrenal function. J Am Acad Dermatol 1987;16: 804-11.

  116. Runne U, Kunze J. Short-duration ("minutes") therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 1982;106:135-9.

  117. Marsden JR, Coburn PR, Marks J, Shuster S. Measurement of the response of psoriasis to short-term application of anthralin. Br J Dermatol 1983;109: 209-18.

  118. Lowe NJ, Ashton RE, Koudsi H, Verschoore M, Schaefer H. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. J Am Acad Dermatol 1984;10:69-72.

  119. Dodd WA. Tars: their role in the treatment of psoriasis. Dermatol Clin 1993;11:131-5.

  120. Stewart AF, Battaglini-Sabetta J, Millstone L. Hypocalcemia-induced pustular psoriasis of von Zumbusch. New experiences with an old syndrome. Ann Intern Med 1984;100:677-80.

  121. Morimoto S, Kumahara Y. A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Med J Osaka Univ 1985;35:51-4.

  122. Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larko O, et al. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991;337:193-6 [Published erratum in Lancet 1991;337:988].

  123. Cunliffe WJ, Berth-Jones J, Claudy A, Fairiss G, Goldin D, Gratton D, et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992;26(5 Pt 1):736-43.

  124. Berth-Jones J, Chu AC, Dodd WA, Ganpule M, Griffiths WA, Haydey RP, et al. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992;127:266-71.

  125. Tham SN, Lun KC, Cheong WK. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis. Br J Dermatol 1994;131:673-7.

  126. Ramsay CA. Management of psoriasis with calcipotriol used as monotherapy. J Am Acad Dermatol 1997;37(3 Pt 2):S53-4.

  127. Kirsner RS, Federman D. Treatment of psoriasis: role of calcipotriene. Am Fam Physician 1995;52: 237-40.

  128. Weinstein GD, Krueger GG, Lowe NJ, Duvic M, Friedman DJ, Jegasothy BV, et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 1997;37:85-92.